New data show favorable outcomes with subcutaneous infliximab following intravenous infliximab interruption, regardless of prior antibody status, in adult patients with moderate to...
SINGAPORE, Aug. 25, 2025 /PRNewswire/ -- Two straight weeks of pure pickleball action is on the horizon, with PPA Tour Asia bringing back-to-back Cups to...
SINGAPORE, Aug. 25, 2025 /PRNewswire/ -- Longbridge Group, a leading financial technology innovator, today announced that it has added the Cboe Global Indices Feed...
SAN FRANCISCO and SUZHOU, China, Aug. 25, 2025 /PRNewswire/ -- Innovent Biologics, Inc. ("Innovent") (HKEX: 01801), a world-class biopharmaceutical company committed to developing, manufacturing...